Literature DB >> 21682288

Quantitative analysis of the leaky expression of adenovirus genes in cells transduced with a replication-incompetent adenovirus vector.

Kahori Shimizu1, Fuminori Sakurai, Mitsuhiro Machitani, Kazufumi Katayama, Hiroyuki Mizuguchi.   

Abstract

Theoretically, adenovirus (Ad) genes should not be expressed following transduction with a replication-incompetent Ad vector because the E1A gene, which is essential for the expression of other viral gene, is deleted in a replication-incompetent Ad vector. However, leaky expression of viral genes is known to occur following transduction with an E1-deleted Ad vector, leading to an induction of cellular immunity against Ad proteins. To date, no detailed analysis of the leaky expression profiles of Ad genes has been performed. In this study, we systematically examined the expression profiles of Ad genes in cells following transduction with a replication-incompetent Ad vector (Ad-L2) at multiplicities of infection (MOIs) of 10 and 100 using real-time RT-PCR. Significant expression was found for the E4 and pIX genes following transduction with Ad-L2 in cultured cells. The expression levels of the E4 and pIX genes were approximately 30- to 600-fold lower than those of the transgene (firefly luciferase), and 50- to 5000-fold lower than those of the E4 and pIX genes following transduction at the same MOI with the wild-type Ad. Unexpectedly, expression levels of the major capsid proteins were approximately the same as, or even slightly above, the background levels (Ad gene expression levels in mock-transduced cells). This study provides valuable information for the design of a safe and efficient replication-incompetent Ad vector.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21682288     DOI: 10.1021/mp200121z

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  10 in total

Review 1.  Ferret and pig models of cystic fibrosis: prospects and promise for gene therapy.

Authors:  Ziying Yan; Zoe A Stewart; Patrick L Sinn; John C Olsen; Jim Hu; Paul B McCray; John F Engelhardt
Journal:  Hum Gene Ther Clin Dev       Date:  2015-02-12       Impact factor: 5.032

2.  Chromatin structure of two genomic sites for targeted transgene integration in induced pluripotent stem cells and hematopoietic stem cells.

Authors:  R van Rensburg; I Beyer; X-Y Yao; H Wang; O Denisenko; Z-Y Li; D W Russell; D G Miller; P Gregory; M Holmes; K Bomsztyk; A Lieber
Journal:  Gene Ther       Date:  2012-03-22       Impact factor: 5.250

3.  Suppression of leaky expression of adenovirus genes by insertion of microRNA-targeted sequences in the replication-incompetent adenovirus vector genome.

Authors:  Kahori Shimizu; Fuminori Sakurai; Kyoko Tomita; Yasuhito Nagamoto; Shin-Ichiro Nakamura; Kazufumi Katayama; Masashi Tachibana; Kenji Kawabata; Hiroyuki Mizuguchi
Journal:  Mol Ther Methods Clin Dev       Date:  2014-09-03       Impact factor: 6.698

4.  Lung gene therapy-How to capture illumination from the light already present in the tunnel.

Authors:  Emily Xia; Manjunatha Ankathatti Munegowda; Huibi Cao; Jim Hu
Journal:  Genes Dis       Date:  2014-09

5.  Efficient genome editing in hematopoietic stem cells with helper-dependent Ad5/35 vectors expressing site-specific endonucleases under microRNA regulation.

Authors:  Kamola Saydaminova; Xun Ye; Hongjie Wang; Maximilian Richter; Martin Ho; HongZhuan Chen; Ning Xu; Jin-Soo Kim; Eirini Papapetrou; Michael C Holmes; Philip D Gregory; Donna Palmer; Philip Ng; Anja Ehrhardt; André Lieber
Journal:  Mol Ther Methods Clin Dev       Date:  2015-01-14       Impact factor: 6.698

6.  Adenovirus Vector-Derived VA-RNA-Mediated Innate Immune Responses.

Authors:  Mitsuhiro Machitani; Tomoko Yamaguchi; Kahori Shimizu; Fuminori Sakurai; Kazufumi Katayama; Kenji Kawabata; Hiroyuki Mizuguchi
Journal:  Pharmaceutics       Date:  2011-07-11       Impact factor: 6.321

7.  The Human Adenovirus Type 5 E4orf6/E1B55K E3 Ubiquitin Ligase Complex Can Mimic E1A Effects on E2F.

Authors:  Frédéric Dallaire; Sabrina Schreiner; G Eric Blair; Thomas Dobner; Philip E Branton; Paola Blanchette
Journal:  mSphere       Date:  2015-11-11       Impact factor: 4.389

8.  Neonatal Gene Therapy for Hemophilia B by a Novel Adenovirus Vector Showing Reduced Leaky Expression of Viral Genes.

Authors:  Shunsuke Iizuka; Fuminori Sakurai; Masashi Tachibana; Kazuo Ohashi; Hiroyuki Mizuguchi
Journal:  Mol Ther Methods Clin Dev       Date:  2017-07-08       Impact factor: 6.698

9.  SARS-CoV-2 vaccine ChAdOx1 nCoV-19 infection of human cell lines reveals low levels of viral backbone gene transcription alongside very high levels of SARS-CoV-2 S glycoprotein gene transcription.

Authors:  Abdulaziz Almuqrin; Andrew D Davidson; Maia Kavanagh Williamson; Philip A Lewis; Kate J Heesom; Susan Morris; Sarah C Gilbert; David A Matthews
Journal:  Genome Med       Date:  2021-03-15       Impact factor: 11.117

10.  NF-κB promotes leaky expression of adenovirus genes in a replication-incompetent adenovirus vector.

Authors:  M Machitani; F Sakurai; K Wakabayashi; K Nakatani; K Shimizu; M Tachibana; H Mizuguchi
Journal:  Sci Rep       Date:  2016-01-27       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.